Aether and Procter & Gamble partner up to develop cutting edge 3D printing and AI technologies

Aether, the San Francisco-based startup offers AI-enhanced 3D bioprinting. As a matter of fact, it has just received a two-year joint agreement with Procter & Gamble (P&G), a multinational consumer goods giant. The two companies have announced they will work together to further develop breakthrough 3D printing and AI technologies.

A collaboration to develop the relationship between 3D printing and AI

One of the aims behind this collaboration is to introduce a new, next generation Aether 3D printer. As of now, Aether has one printer on the market, Aether 1. The former is a multi-material 3D bioprinter with a multi-tool hybrid manufacturing system unified into a single device. It uses artificial intelligence to automate difficult and time-consuming tasks. The materials with which it can print include viscous pastes, gels, ABS/PLA and most filaments, liquids, ceramics and foods. We also reported at the end of January that Aether, UCL and Loughborough University were developing an ink containing nanoparticles to act as a nanosurgical tool.

Photo: Business Wire

Ryan Franks, CEO and Founder of Aether said for a recent press release, “Aether is working with P&G to completely redefine 3D printing. It’s no longer going to be just about depositing a material or two in a specific pattern. We’re building something more like an intelligent robotic craftsman, able to perform highly complex tasks with many different tools, visually evaluate and correct its work throughout the fabrication process, and constantly learn how to improve”.